There are 2934 resources available
Does surgery still have a role in stage III NSCLC in the era of immunotherapy? The surgeon’s view
Presenter: Ad Verhagen
Session: Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Resources:
Slides
Webcast
5756 - Randomized phase II study of CAPTEM versus FOLFIRI in RAS mutated, MGMT methylated metastatic colorectal cancer (mCRC): final analysis, tumor biomarkers and methylated ctDNA
Presenter: Filippo Pietrantonio
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract
Poster Discussion – Gastrointestinal tumours, colorectal - Invited Discussant LBA35, LAB36, 526PD and 527PD
Presenter: Ramon Salazar
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, colorectal - Invited Discussant 528PD, 529PD, 530PD and 531PD
Presenter: Pia Österlund
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, colorectal - Invited Discussant 532PD and 533PD
Presenter: Demetris Papamichael
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 904PD, 905PD and 906PD
Presenter: Joaquim Bellmunt
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 907PD, 908PD, 909PD and 910PD
Presenter: Guillermo A. De Velasco Oria de Rueda
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 911PD and 912PD
Presenter: Viktor Gruenwald
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 913PD, 914PD and 915PD
Presenter: Christian Kollmannsberger
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
3974 - 177Lu-DOTATATE plus 166Ho-radioembolization in patients with neuroendocrine tumours; a single center, prospective, interventional, non-comparative, open label, phase II study (HEPAR PLUS study)
Presenter: Sander Ebbers
Session: Proffered Paper – NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast